Celsion GmbH, a wholly-owned auxiliary of Celsion Corporation (NASDAQ: CLSN), commences enrollment in Phase I PanDox clinical trial using ThermoDox and FUS (Focused Ultrasound) patients to cure pancreatic cancer.  MHRA gives the nod for clinical trial The oxford university-sponsored investigator-led clinical trial supported by NIHR (National Institute for Health Research) received […]